Charles M. Cohen
Director/Board Member at Sirion Holdings, Inc.
Profile
Charles M.
Cohen founded Synthesis Capital in 2007, where he worked as Principal from 2007 to 2012, Creative Biomolecules, Inc. in 1982, where he worked as Chief Executive Officer & Director from 1985 to 1995, Cellzome Ltd.
in 2000, where he worked as Chairman, Aureon Biosciences, Inc. in 2001, where he worked as Director, Trident Pharmaceuticals, Inc. in 2006, where he worked as President & Chief Executive Officer from 2006 to 2011, and Prexa Pharmaceuticals, Inc. in 2006, where he worked as Chairman & Chief Executive Officer.
Dr. Cohen also currently works at Sirion Holdings, Inc., as Director.
Dr. Cohen also formerly worked at Ampla Pharmaceuticals, Inc., as President, Chief Executive Officer & Director, On Target Therapeutics, LLC, as Chief Executive Officer & Director from 2015 to 2017, Perform Biologics, Inc., as Chief Executive Officer & Director from 2015 to 2019, Cellzome AG, as Chairman-Supervisory Board from 2002 to 2012, Exelixis, Inc., as Independent Director from 1995 to 2022, Archemix Corp., as Director, Anesiva, Inc., as Director from 2005 to 2007, Anadys Pharmaceuticals, Inc., as Director from 2000 to 2005, ReVision Therapeutics, Inc., as Director, AlgoRx Pharmaceuticals, Inc., as Director, Advent International LP, as Partner, and Painewebber Group, Inc., as Advisor from 1998 to 2001.
Dr. Cohen received his undergraduate degree from State University of New York at Buffalo and doctorate degree from New York University School of Medicine.
Charles M. Cohen active positions
| Companies | Position | Start |
|---|---|---|
Sirion Holdings, Inc.
 Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | Director/Board Member | 2010-05-16 |
Former positions of Charles M. Cohen
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | Director/Board Member | 2022-05-24 |
Perform Biologics, Inc.
 Perform Biologics, Inc. BiotechnologyHealth Technology Perform Biologics, Inc. develops biotechnologies. The private company is based in Wilmington, DE. | Chief Executive Officer | 2019-04-30 |
On Target Therapeutics, LLC
 On Target Therapeutics, LLC Pharmaceuticals: MajorHealth Technology On Target Therapeutics, LLC is a pharmaceutical company that manufactures pharmaceuticals. The private company is based in Weston, MA. | Chief Executive Officer | 2017-05-31 |
Synthesis Capital
 Synthesis Capital Investment ManagersFinance Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts. | Founder | 2015-11-30 |
Cellzome AG
 Cellzome AG Miscellaneous Commercial ServicesCommercial Services Cellzome AG provides drug discovery services. It is a research company with proprietary proteomics technology for target and lead identification and a drug discovery program in Alzheimer's disease. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Chief Executive Officer | 2001-12-31 |
Training of Charles M. Cohen
| State University of New York at Buffalo | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Private companies | 18 |
|---|---|
Advent International LP
 Advent International LP Investment ManagersFinance Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts. | Finance |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Health Technology |
Aureon Biosciences, Inc.
 Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Health Technology |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | Health Technology |
Trident Pharmaceuticals, Inc.
 Trident Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trident Pharmaceuticals, Inc. develops novel biologics for the treatment of autoimmune disorders. The company was founded by Charles M. Cohen and Robin Brown in March 2006 and is headquartered in Boston, MA. | Health Technology |
Ampla Pharmaceuticals, Inc.
 Ampla Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ampla Pharmaceuticals, Inc. engages in the drug discovery of novel oral small molecule drugs for treatment of diabetes and metabolism disorders. It also designs and develops biopharmaceutical drugs. The company was founded by James R. Hauske and Eric Bednarski in 2006 and is headquartered in La Jolla, CA. | Health Technology |
Prexa Pharmaceuticals, Inc.
 Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prexa Pharmaceuticals, Inc. developed oral small molecule monoamine reuptake inhibitors that act potently at the dopamine transporter. It engaged in developing small molecules designed to enhance the action of the neurotransmitter dopamine, potentially providing new alternatives to treating CNS diseases and disorders such as ADHD, depression, and Parkinson's disease. The company was founded in 2006 and was headquartered in Boston, MA. | Health Technology |
ReVision Therapeutics, Inc.
 ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. The firm operates as a ophthalmic biopharmaceutical company. Its products include Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in April 2010 and is headquartered in La Jolla, CA. | Retail Trade |
| Painewebber Group, Inc. | Finance |
AlgoRx Pharmaceuticals, Inc.
 AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ. | Health Technology |
Cellzome AG
Cellzome AG Miscellaneous Commercial ServicesCommercial Services Cellzome AG provides drug discovery services. It is a research company with proprietary proteomics technology for target and lead identification and a drug discovery program in Alzheimer's disease. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Commercial Services |
Synthesis Capital
Synthesis Capital Investment ManagersFinance Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts. | Finance |
On Target Therapeutics, LLC
On Target Therapeutics, LLC Pharmaceuticals: MajorHealth Technology On Target Therapeutics, LLC is a pharmaceutical company that manufactures pharmaceuticals. The private company is based in Weston, MA. | Health Technology |
Perform Biologics, Inc.
Perform Biologics, Inc. BiotechnologyHealth Technology Perform Biologics, Inc. develops biotechnologies. The private company is based in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Charles M. Cohen